|
Market Closed -
Oslo Bors
10:45:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.8140 NOK | -8.54% |
|
-15.03% | -81.07% |
| 08-13 | Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-06 | Induct AS Announces Chief Financial Officer Changes | CI |
Projected Income Statement: Induct
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net sales 1 | 16.58 | 15.93 | 18.1 | 24.5 |
| Change | - | -3.94% | 13.62% | 35.36% |
| EBITDA 1 | - | 5.5 | 8.2 | 12.9 |
| Change | - | - | 49.09% | 57.32% |
| EBIT 1 | - | -6.7 | -3.9 | 0.7 |
| Change | - | - | 41.79% | 117.95% |
| Interest Paid 1 | - | -0.2 | -0.4 | -0.6 |
| Earnings before Tax (EBT) 1 | - | -6.9 | -4.4 | 0.1 |
| Change | - | - | 36.23% | 102.27% |
| Net income 1 | -7.14 | -7 | -4.6 | -0.4 |
| Change | - | 1.96% | 34.29% | 91.3% |
| Announcement Date | 2/12/26 | - | - | - |
1NOK in Million
Estimates
Forecast Balance Sheet: Induct
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net Debt 1 | - | 9.7 | 15.3 | 17.8 |
| Change | - | - | 57.73% | 16.34% |
| Announcement Date | 2/12/26 | - | - | - |
1NOK in Million
Estimates
Cash Flow Forecast: Induct
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| CAPEX 1 | 9 | 9 | 9 |
| Change | - | 0% | 0% |
| Free Cash Flow (FCF) 1 | -4 | -3 | - |
| Change | - | 25% | 100% |
| Announcement Date | - | - | - |
1NOK in Million
Estimates
Forecast Financial Ratios: Induct
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | - | 34.53% | 45.3% | 52.65% |
| EBIT Margin (%) | - | -42.06% | -21.55% | 2.86% |
| EBT Margin (%) | - | -43.31% | -24.31% | 0.41% |
| Net margin (%) | -43.05% | -43.94% | -25.41% | -1.63% |
| FCF margin (%) | - | -25.11% | -16.57% | - |
| FCF / Net Income (%) | - | 57.14% | 65.22% | - |
Profitability | ||||
| ROA | - | - | - | - |
| ROE | - | -21.9% | -17.9% | 15.6% |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | 1.76x | 1.87x | 1.38x |
| Debt / Free cash flow | - | -2.42x | -5.1x | - |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | 56.5% | 49.72% | 36.73% |
| CAPEX / EBITDA (%) | - | 163.64% | 109.76% | 69.77% |
| CAPEX / FCF (%) | - | -225% | -300% | - |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| EPS 1 | - | -0.22 | -0.15 | -0.01 |
| Change | - | - | 31.82% | 93.33% |
| Nbr of stocks (in thousands) | - | 31,309 | 31,309 | 31,309 |
| Announcement Date | - | - | - | - |
1NOK
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | -3.7x | -5.43x |
| PBR | - | - |
| EV / Sales | 2.21x | 2.25x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.8140NOK
Average target price
1.180NOK
Spread / Average Target
+44.96%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- INDCT Stock
- Financials Induct
Select your edition
All financial news and data tailored to specific country editions
















